Tom French, 3P innovation - Qepler Summits And Conferences

Tom French

Device Industrialisation Engineer
3P innovation
United Kingdom
Custom Automation Systems | 3P Innovation - company which specialise in powder filling solutions

Related Sessions:

2nd Annual Inhaled
Drug Delivery Summit 2021

Assess and harness novel approaches to the development of inhaled drug products for enhanced patient care.
  • 05 Aug 2021
  • Virtual,
  • Pharma
Day 2: Friday, 06 August 2021
CASE STUDY: The impact of filling technology selection for dry powder formulations on device performance, process consistency and commercial scale-up
  • Consistent high efficiency aerosoliation performance is a critical quality attribute for all dry powder inhalers. There is a strong dependant relationship between the powder formulation, filling technology, device design and the device performance.
  • The desire to deliver a wider range of molecular types of drug has promoted a large increase in the use of engineered particle technologies e.g. spray drying for DPIs which require careful consideration of process conditions.
  • Highlight the impact of filling technology on device performance, process efficiency and manufacturing throughput. Could selection of the right filling technologies enable increased formulation and device design spaces.
  • Assess the potential issues due to filling technology with process scale-up to achieve continuity of performance as you move from bench, through clinic to commercial; minimising risk in the development process.
  • Affirm the importance of early stage filling trials on formulation selection and device design.
View Details